Clorox (CLX) Stock Forecast & Price Target
$10.73B
Market Cap
18.02
P/E
15.58
Forward P/E
48
Score
CLX price $88.69 +1.85 +2.13%
Stocklytics score rationale: value 62, quality 55, growth 26.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 5973000000 | 6124000000 | 6214000000 | 6721000000 | 7341000000 | 7107000000 | 7389000000 | 7093000000 | 7104000000 | 6720000000 |
The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula…
Consensus Hold from 18 analysts. Average price target $90.43, +2.0% versus the current price. Low $80.00. High $99.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $90.43 for The Clorox (CLX), 2.0% above the current price of $88.69. Of 18 analysts covering the stock, 1 rate it Buy or Strong Buy, 13 Hold, and 4 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $80.00 |
|---|---|
| Average | $90.43 |
| High | $99.00 |
The average is 2.0% above the current price of $88.69.
Of 18 analysts, 1 rate The Clorox Buy or Strong Buy, 13 Hold, and 4 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $5.52, revenue $6.68 billion. 2027, EPS $5.69, revenue $7.63 billion.
The Stocklytics Score for CLX is 48 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$90.43 average, with a published range of $80.00 to $99.00.
The consensus is Hold from 18 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $5.52. The average revenue estimate is $6.68 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: The Clorox · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$10.73B
Market Cap
18.02
P/E
15.58
Forward P/E
48
Score